Poland· PL-100454626
Allergodil SPRINT
A azelastine product containing azelastini hydrochloridum, registered in Poland by Cooper Consumer Health B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Azelastine is registered in 11 of 19 countries.
Countries holding a registration under ATC R01AC03 (azelastine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Azelastine · ATC R01AC03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Azelastini hydrochloridum
- Manufacturer
- Cooper Consumer Health B.V.
- Country
- Poland (PL)
- ATC code
- R01AC03
- ATC class
- Azelastine
- Defined daily dose
- 0.56 mg, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05901797711023
- gtin05901797711009
- gtin05901797711030
- gtin05901797711054
- gtin05901797711047
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for azelastine.
Graded by severity as the source publishes them — 200 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Azelastine · interactions on record
201 records
- 200 moderate
- 1 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- TriflupromazinA04AD06moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Azelastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandAsteproCooper Consumer Health B.V.
- NetherlandsAstepro 1,5 mg/ml neusspray, oplossingCooper Consumer Health B.V.
- SpainASTEPRO 1,5 MG/ML SOLUCION PARA PULVERIZACION NASALCooper Consumer Health B.V.
- FranceALONEST 1,5 mg/mL, solution pour pulvérisation nasaleVIATRIS MEDICAL
- IrelandAstepro 1.5 mg/ml nasal spray, solutionCooper Consumer Health B.V.
- United StatesAstepro AllergyBayer HealthCare LLC.
- CzechiaALLERGODILVIATRIS HEALTHCARE LIMITED, Dublin
- GermanyAllergo-AzelindDoppelherz Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Allergodil, Allergospray
- Belgium · Allergodil, Azelergo
- Bulgaria · Алергодил, Анталерг
- Czechia · Allergodil, Allergodil Forte
- Germany · Allergo-Azelind, Allergodil
- Denmark · Allergodil, Allergodil Forte
- Estonia · Allergodil
- Spain · Afluon, Afluón
- Finland · Lastin
- France · Allergodil, Alonest
- United Kingdom (Northern Ireland) · Astepro, Azelair
- Greece · Afluon
- Croatia · Vivialle, Vivispray
- Hungary · Allergodil, Allergodil Forte
- Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
- Iceland · Astepro, Lastin
- Italy · Allergodil, Allespray
- Lithuania · Allergodil
- Luxembourg · Allergodil, Azelergo
- Latvia · Allergodil
- Malta · Antalerg Unimed Pharma, Azelastin-Comod
- Netherlands · Allergodil, Allergodil Nevel
- Norway · Lastin
- Portugal · Allergodil, Astepro
- Romania · Allegodil, Allergodil
- Sweden · Azelastine Omnivision
- Slovenia · Alezaxin, Allergodil
- Slovakia · Allergodil, Antalerg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a6f819a-0bb0-4bcd-b0d7-e70c3ba35f62 GET /v1/drugs/2a6f819a-0bb0-4bcd-b0d7-e70c3ba35f62?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do nosa, roztwór",
"source": "urpl",
"strength": "1,5 mg/ml",
"packaging": "05901797711023 ¦ OTC ¦ 140965\n1 butelka 5 ml\n05901797711009 ¦ OTC ¦ 140966\n1 butelka 10 ml\n05901797711030 ¦ OTC ¦ 140967\n1 butelka 17 ml\n05901797711054 ¦ OTC ¦ 140968\n1 butelka 22 ml\n05901797711047 ¦ OTC ¦ 140969\n1 butelka 20 ml",
"substance": "Azelastini hydrochloridum 1.5 mg/ml",
"common_name": "Azelastini hydrochloridum",
"pl_product_id": "100454626",
"pozwolenie_nr": "27800",
"auth_procedure": "NAR",
"authorisation_validity": "2028-04-20"
}See everything about azelastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.